Home
Technology
Cardioids
Publications
Platform
Disease Models
Assays
Automation
Data Analysis
Quality Control
Case Studies
Drug Discovery
Pipeline
Cardiomyopathies
Myocardial Fibrosis
Discovery Strategy
Partnering Strategy
About
Mission
Management
Scientific Advisory
Supervisory
Partners
News
Press Releases
In The Media
Conferences
Careers
Contact
Menu
News
Press Releases
View All
HeartBeat.bio engages Stanko Skrtic as Chief Development Officer
September 17, 2026
HeartBeat.bio and Cubase Bio Partner to Advance 3D Spatial Transcriptomics for Cardiovascular Drug Discovery
September 8, 2026
Axxam validates cardiac organoid platform developed by Molecular Devices and HeartBeat.bio for drug discovery and early derisking
August 12, 2026
Molecular Devices and HeartBeat.bio Help Researchers Identify Cardiac Safety Risks Earlier with New Human Cardiac Organoid Solution
August 10, 2026
Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
July 9, 2026
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
September 23, 2025
Press Releases
View All
HeartBeat.bio engages Stanko Skrtic as Chief Development Officer
September 17, 2026
HeartBeat.bio and Cubase Bio Partner to Advance 3D Spatial Transcriptomics for Cardiovascular Drug Discovery
September 8, 2026
Axxam validates cardiac organoid platform developed by Molecular Devices and HeartBeat.bio for drug discovery and early derisking
August 12, 2026
Molecular Devices and HeartBeat.bio Help Researchers Identify Cardiac Safety Risks Earlier with New Human Cardiac Organoid Solution
August 10, 2026
Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
July 9, 2026
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
September 23, 2025
In The Media
View All
The Scientist
Beating Cardiac Organoids Offer a Platform for Drug Screening
September 30, 2026
Galen Growth
HealthTech 250: The Most Promising Early-Stage Digital Health Ventures of 2025
March 4, 2025
Zefyron
Top 10 Early-Stage Life Sciences Startups
February 2, 2025
EU-Startups
10 Fast-Growing Austrian Startups to Watch Closely in 2025
January 2, 2025
StartUs Insights
Discover 20 Innovative Pharma Startups to Watch (2024)
July 31, 2024
Startup Stash
40 Best Austrian Startups to Watch in 2024
July 18, 2024
Die Macher
Verantwortung übernehmen, nachhaltig investieren
November 29, 2023
Molecular Devices
Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
October 16, 2023
Die Presse
In Laborschalen wachsen Herzkammern im Miniformat. Die Technik bildet menschliche Organe nach und kann in der Forschung den Einsatz von Tierexperimenten verringern
October 15, 2022
Connect With Us At...
View All
No items found.
Press Releases
In The Media
Conferences
